Hepatitis Diagnostic Tests Global Market Report 2024

Description

Hepatitis diagnostic tests are medical procedures and laboratory analyses designed to identify and diagnose infections caused by hepatitis viruses, including hepatitis A, B, C, D, and E. These tests are essential for detecting the presence of hepatitis viruses or specific antibodies in a patient's blood or other bodily fluids. The primary goal is to confirm the infection, determine its type, assess severity, and monitor its progression.

The main categories of hepatitis diagnostic tests include blood tests, imaging tests, and liver biopsy. Blood tests involve examining blood samples to assess various constituents such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. Various technologies are utilized in these tests, including enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification tests, and others. These diagnostic tools find applications in diverse healthcare settings such as hospitals, diagnostic laboratories, blood banks, and other medical facilities.

The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides hepatitis diagnostic tests market statistics, including hepatitis diagnostic tests industry global market size, regional shares, competitors with a hepatitis diagnostic tests market share, detailed hepatitis diagnostic tests market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis diagnostic test industry. This hepatitis diagnostic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.35 billion in 2023 to $4.64 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed during the historic period in the field of hepatitis diagnostic tests can be attributed to several key factors. These include the globalization of healthcare, government initiatives aimed at improving diagnostic capabilities, the high disease burden associated with hepatitis infections, heightened measures for blood safety, and public health campaigns focused on raising awareness and encouraging testing. These factors collectively contributed to the expansion and adoption of hepatitis diagnostic tests during the historical period.

The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $5.85 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period for hepatitis diagnostic tests can be attributed to several key drivers. These include heightened concerns about global health security, population growth and urbanization trends, the implementation of tailored testing strategies, a strong emphasis on elimination programs for hepatitis, and the overall increase in healthcare spending worldwide. Major trends expected in the forecast period include advancements in testing technologies, particularly in the field of molecular diagnostics, the development of multiplex testing for different hepatitis viruses, integration of digital health solutions for improved diagnostics and monitoring, and an increase in strategic collaborations and partnerships within the healthcare sector. These trends collectively contribute to the projected growth and evolution of hepatitis diagnostic testing in the coming period.

The rising number of blood transfusions and blood donations plays a crucial role in driving the growth of the hepatitis diagnostic test market. Blood transfusions and donations are intertwined processes where individuals willingly contribute blood that undergoes collection, rigorous testing, and subsequent administration to patients who require additional blood components due to various medical conditions, surgeries, accidents, or illnesses. To ensure the safety of recipients, hepatitis diagnostic tests are utilized to thoroughly screen donated blood, thereby reducing the risk of transmitting hepatitis through transfusions. For example, data from NHS Blood and Transplant (NHSBT) in December 2021 indicated an increase in whole blood donations in the UK to 1,719,630 by 963,145 donors in 2021, compared to 1,649,057 by 933,705 donors in 2020. This rise in blood donations signifies an increased need for hepatitis diagnostic tests to maintain the safety and quality of donated blood, subsequently driving the hepatitis diagnostic test market.

The surge in hepatitis cases globally is another key factor propelling the growth of the hepatitis diagnostic tests market. Hepatitis, characterized by liver inflammation, poses significant health risks and can lead to various symptoms and complications. Accurate diagnostic tests for hepatitis are crucial in identifying and confirming the presence of hepatitis infections, enabling timely interventions and effective disease management. For instance, according to the Hepatitis B Foundation in 2023, an estimated 1.5 million people contract hepatitis infections annually, highlighting the persistent challenge posed by these diseases. The growing incidence of hepatitis underlines the critical importance of reliable diagnostic tests in early detection and management, thereby fueling the demand for hepatitis diagnostic tests in the market.

The projected impediment to the growth of the hepatitis diagnostic test market stems from the high cost associated with these tests. The considerable expenses related to hepatitis diagnostic procedures are a significant concern for both individuals and healthcare systems. This financial burden could lead to delayed diagnoses, insufficient monitoring, and escalated healthcare expenditures over time. As indicated by a report in April 2023 from the Lancet, the costs attributed to Hepatitis Diagnostic tests range from $890 to $1406, marking an increase of up to 35% compared to standard care treatments. Consequently, the exorbitant cost of these diagnostic tests stands as a hindrance to the market's expansion.

Dominant players in the hepatitis diagnostic test market are concentrating on innovating automated immunoassays, exemplified by the Elecsys HCV Duo, to enhance customer service reliability. Automated immunoassays represent laboratory techniques utilizing automated systems and specialized instruments to conduct various phases of the immunoassay process, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, a biotechnology research company based in India, introduced Elecsys HCV Duo. This advanced solution represents India's maiden fully automated immunoassay available commercially, facilitating the simultaneous and independent evaluation of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. Moreover, this approach streamlines the diagnostic procedure, enabling single-specimen testing and potentially reducing the number of necessary follow-up visits, consequently alleviating the burden on healthcare systems.

In August 2021, BioCheck Inc., a US-based company specializing in diagnostic products, completed the acquisition of DRG International Inc. The exact amount of the acquisition remains undisclosed. This strategic move by BioCheck aims to expedite the accessibility of enhanced and dependable advanced clinical and research diagnostic tests designed for various diseases. DRG International Inc., another US-based entity acquired by BioCheck, is recognized for its repertoire of diagnostic tests, notably including those for hepatitis diagnostics.

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

North America was the largest region in the hepatitis diagnostic tests market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hepatitis diagnostic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis Diagnostic Tests Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis diagnostic tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis diagnostic tests? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis diagnostic tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Test Type: Blood Tests; Imaging Tests; Liver Biopsy
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests (RDTs); Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Test (INAAT); Other Technologies
3) By End User: Hospitals; Diagnostic Laboratories; Blood Bank; Other End Users
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Roche Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13366

1. Executive Summary

2. Hepatitis Diagnostic Tests Market Characteristics

3. Hepatitis Diagnostic Tests Market Trends And Strategies

4. Hepatitis Diagnostic Tests Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Hepatitis Diagnostic Tests Market Size and Growth

5.1. Global Hepatitis Diagnostic Tests Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hepatitis Diagnostic Tests Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hepatitis Diagnostic Tests Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hepatitis Diagnostic Tests Market Segmentation

6.1. Global Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Blood Tests
Imaging Tests
Liver Biopsy
6.2. Global Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDTs)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Test (INAAT)
Other Technologies
6.3. Global Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Diagnostic Laboratories
Blood Bank
Other End Users

7. Hepatitis Diagnostic Tests Market Regional And Country Analysis

7.1. Global Hepatitis Diagnostic Tests Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hepatitis Diagnostic Tests Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hepatitis Diagnostic Tests Market

8.1. Asia-Pacific Hepatitis Diagnostic Tests Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hepatitis Diagnostic Tests Market

9.1. China Hepatitis Diagnostic Tests Market Overview
9.2. China Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hepatitis Diagnostic Tests Market

10.1. India Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hepatitis Diagnostic Tests Market

11.1. Japan Hepatitis Diagnostic Tests Market Overview
11.2. Japan Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hepatitis Diagnostic Tests Market

12.1. Australia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hepatitis Diagnostic Tests Market

13.1. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hepatitis Diagnostic Tests Market

14.1. South Korea Hepatitis Diagnostic Tests Market Overview
14.2. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hepatitis Diagnostic Tests Market

15.1. Western Europe Hepatitis Diagnostic Tests Market Overview
15.2. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hepatitis Diagnostic Tests Market

16.1. UK Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hepatitis Diagnostic Tests Market

17.1. Germany Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hepatitis Diagnostic Tests Market

18.5. France Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hepatitis Diagnostic Tests Market

19.9. Italy Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hepatitis Diagnostic Tests Market

20.13. Spain Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hepatitis Diagnostic Tests Market

21.1. Eastern Europe Hepatitis Diagnostic Tests Market Overview
21.2. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hepatitis Diagnostic Tests Market

22.1. Russia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hepatitis Diagnostic Tests Market

23.1. North America Hepatitis Diagnostic Tests Market Overview
23.2. North America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hepatitis Diagnostic Tests Market

24.1. USA Hepatitis Diagnostic Tests Market Overview
24.2. USA Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hepatitis Diagnostic Tests Market

25.1. Canada Hepatitis Diagnostic Tests Market Overview
25.2. Canada Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hepatitis Diagnostic Tests Market

26.1. South America Hepatitis Diagnostic Tests Market Overview
26.2. South America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hepatitis Diagnostic Tests Market

27.1. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hepatitis Diagnostic Tests Market

28.1. Middle East Hepatitis Diagnostic Tests Market Overview
28.2. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hepatitis Diagnostic Tests Market

29.1. Africa Hepatitis Diagnostic Tests Market Overview
29.2. Africa Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hepatitis Diagnostic Tests Market Competitive Landscape And Company Profiles

30.1. Hepatitis Diagnostic Tests Market Competitive Landscape
30.2. Hepatitis Diagnostic Tests Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Danaher Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Siemens Healthineers AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Roche Diagnostics
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Hepatitis Diagnostic Tests Market Other Major And Innovative Companies

31.1. Quest Diagnostics Incorporated
31.2. Grifols S.A
31.3. Hologic Inc.
31.4. BioMerieux SA
31.5. Beckman Coulter Inc.
31.6. Bio-Rad Laboratories Inc.
31.7. SD Biosensor Co. Ltd.
31.8. QIAGEN N.V.
31.9. DiaSorin S.p.A.
31.10. Randox Laboratories Ltd.
31.11. Luminex Corporation
31.12. Fujirebio Diagnostics Inc.
31.13. Trivitron Healthcare Private Limited
31.14. Trinity Biotech plc
31.15. MP Biomedicals LLC

32. Global Hepatitis Diagnostic Tests Market Competitive Benchmarking

33. Global Hepatitis Diagnostic Tests Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hepatitis Diagnostic Tests Market

35. Hepatitis Diagnostic Tests Market Future Outlook and Potential Analysis

35.1 Hepatitis Diagnostic Tests Market In 2028 - Countries Offering Most New Opportunities
35.2 Hepatitis Diagnostic Tests Market In 2028 - Segments Offering Most New Opportunities
35.3 Hepatitis Diagnostic Tests Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer